DM
Deerfield Management Portfolio holdings
AUM
$5.51B
1-Year Return
12.76%
This Quarter Return
-8.37%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$5.26B
AUM Growth
-$1.44B
(-21%)
Cap. Flow
-$1.2B
Cap. Flow
% of AUM
-22.76%
Top 10 Holdings %
Top 10 Hldgs %
53.77%
Holding
466
New
22
Increased
24
Reduced
24
Closed
360
Top Buys
| 1 |
NewAmsterdam Pharma
NAMS
|
+$87.7M |
| 2 |
Dynavax Technologies
DVAX
|
+$66M |
| 3 |
Oscar Health
OSCR
|
+$53.5M |
| 4 |
Legend Biotech
LEGN
|
+$50.5M |
| 5 |
Indivior
INDV
|
+$47.1M |
Top Sells
| 1 |
Nuvalent
NUVL
|
+$157M |
| 2 |
Kura Oncology
KURA
|
+$106M |
| 3 |
Catalyst Pharmaceutical
CPRX
|
+$64.6M |
| 4 |
Neurocrine Biosciences
NBIX
|
+$62.1M |
| 5 |
WAY
Waystar Holding Corp
WAY
|
+$60.8M |
Sector Composition
| 1 | Healthcare | 88.36% |
| 2 | Industrials | 0.23% |
| 3 | Consumer Staples | 0.01% |
| 4 | Energy | 0% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
NB Bancorp
NBBK
$740M
| – | – |
-46,371
| Closed | -$861K |
|
277
NeoGenomics
NEO
$966M
| – | – |
-9,486
| Closed | -$140K |
|
278
Nike
NKE
$110B
| – | – |
-9,310
| Closed | -$823K |
|
279
NNN REIT
NNN
$8.06B
| – | – |
-8,891
| Closed | -$431K |
|
280
Northrop Grumman
NOC
$83B
| – | – |
-1,294
| Closed | -$683K |
|
281
Nutanix
NTNX
$20.7B
| – | – |
-16,429
| Closed | -$973K |
|
282
Novavax
NVAX
$1.29B
| – | – |
-92,597
| Closed | -$1.17M |
|
283
NVIDIA
NVDA
$4.32T
| – | – |
-16,318
| Closed | -$1.98M |
|
284
Enviri
NVRI
$959M
| – | – |
-82,364
| Closed | -$852K |
|
285
Northwest Natural Holdings
NWN
$1.7B
| – | – |
-9,940
| Closed | -$406K |
|
286
NXP Semiconductors
NXPI
$55.3B
| – | – |
-1,496
| Closed | -$359K |
|
287
Old Dominion Freight Line
ODFL
$30.7B
| – | – |
-7,199
| Closed | -$1.43M |
|
288
Omega Healthcare
OHI
$12.6B
| – | – |
-9,509
| Closed | -$387K |
|
289
O-I Glass
OI
$1.95B
| – | – |
-62,673
| Closed | -$822K |
|
290
Oneok
OKE
$46.2B
| – | – |
-5,970
| Closed | -$544K |
|
291
Olema Pharmaceuticals
OLMA
$536M
| – | – |
-33,296
| Closed | -$398K |
|
292
Omnicell
OMCL
$1.46B
| – | – |
-17,651
| Closed | -$770K |
|
293
Onto Innovation
ONTO
$5.2B
| – | – |
-1,073
| Closed | -$223K |
|
294
Option Care Health
OPCH
$4.66B
| – | – |
-23,613
| Closed | -$739K |
|
295
Opko Health
OPK
$1.12B
| – | – |
-22,796
| Closed | -$34K |
|
296
Old Republic International
ORI
$9.92B
| – | – |
-12,645
| Closed | -$448K |
|
297
Oric Pharmaceuticals
ORIC
$1.02B
| – | – |
-78,435
| Closed | -$804K |
|
298
Otter Tail
OTTR
$3.48B
| – | – |
-22,452
| Closed | -$1.75M |
|
299
Oxford Industries
OXM
$604M
| – | – |
-18,184
| Closed | -$1.58M |
|
300
Phibro Animal Health
PAHC
$1.67B
| – | – |
-15,055
| Closed | -$339K |
|